Abstract: The invention provides an alternative extended release dosage form of trospium or its pharmaceutically acceptable salts and methods of preparation thereof. The dosage form of the present invention is bioequivalent to the innovator"s product Sanctura® XR.
| # | Name | Date |
|---|---|---|
| 1 | 516-DEL-2011-Form-1-(02-05-2011).pdf | 2011-05-02 |
| 2 | 516-DEL-2011-Correspondence Others-(02-05-2011).pdf | 2011-05-02 |
| 3 | 516-del-2011-Form-2.pdf | 2011-09-30 |
| 4 | 516-del-2011-Form-1.pdf | 2011-09-30 |
| 5 | 516-del-2011-Description (Complete).pdf | 2011-09-30 |
| 6 | 516-del-2011-Correspondence-others.pdf | 2011-09-30 |
| 7 | 516-del-2011-Claims.pdf | 2011-09-30 |
| 8 | 516-del-2011-Abstract.pdf | 2011-09-30 |